» Authors » J E Reagan

J E Reagan

Explore the profile of J E Reagan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 122
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lindsay R, Cosman F, Lobo R, Walsh B, Harris S, Reagan J, et al.
J Clin Endocrinol Metab . 1999 Sep; 84(9):3076-81. PMID: 10487668
Alendronate and estrogen are effective therapies for postmenopausal osteoporosis, but their efficacy and safety as combined therapy are unknown. The objective of this study was to evaluate the addition of...
2.
Reagan J, Lomax K, Nelson W
HEC Forum . 1997 May; 9(2):120-8. PMID: 10169717
No abstract available.
3.
ROBERTS W, Simon T, Berlin R, Haggitt R, Snyder E, Stenson W, et al.
Gastroenterology . 1997 Mar; 112(3):725-32. PMID: 9041233
Background & Aims: Leukotrienes (LTs) are believed to be important in the pathogenesis of ulcerative colitis (UC). The aim of this study was to determine whether inhibition of LT biosynthesis...
4.
Simon T, ROBERTS W, Berlin R, Hayden L, Berman R, Reagan J
Clin Ther . 1995 Nov; 17(6):1147-56. PMID: 8750406
Control of esophageal acid exposure is important in treating patients with gastroesophageal reflux disease (GERD). After complete healing of esophagitis, most patients will relapse within 6 months if left untreated....
5.
Reagan J
J Law Med Ethics . 1995 Jan; 23(4):398-400; discussion 401-2. PMID: 8715063
No abstract available.
6.
Minogue B, Reagan J
Camb Q Healthc Ethics . 1994 Jan; 3(1):115-24. PMID: 8032512
No abstract available.
7.
Martyn S, Reagan J, Minogue B, Dippel D, Schimer M, Taraszewski R
Akron Law Rev . 1992 Oct; 26(2):229-92. PMID: 16506326
No abstract available.
8.
Cain J, Reagan J
HEC Forum . 1991 Dec; 4(6):378-84. PMID: 10123222
No abstract available.
9.
Chorev M, Roubini E, MCKEE R, Gibbons S, Reagan J, Goldman M, et al.
Peptides . 1991 Jan; 12(1):57-62. PMID: 1647004
Lysine occupies position 13 in the parathyroid hormone (PTH) antagonist, [Nle8,18,Tyr34]bPTH(7-34)NH2. Acylation of the epsilon-amino group in lysine 13 by a hydrophobic moiety is well tolerated in terms of bioactivity:...
10.
Chorev M, Roubini E, Goldman M, MCKEE R, Gibbons S, Reagan J, et al.
Int J Pept Protein Res . 1990 Nov; 36(5):465-70. PMID: 2177456
Position 18 in a parathyroid hormone (PTH) antagonist, [Nle8,18,Tyr34]bPTH(7-34)NH2 (ii), was shown to tolerate substitutions by a range of amino acids with retention of inhibitory activity. The effects of hydrophobic...